CSI Market
Sign In | Register

Verve Therapeutics Inc (VERV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VERV Annual Balance Sheets →
Tracking balance sheet results across Verve Therapeutics Inc to Mar 31 2024 helps illustrate how Mar 31 2025's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent96.55
Marketable Securities, Current SH400.52
Cash & Short-term Investments496.00
Other Current Assets1.40
Prepaid Expense And Other Assets Current13.17
Total Current Assets511.65
Equipment/Property/Plant Net18.46
Other Assets, Noncurrent84.06
Collaboration Receivable1.40
Restricted Cash Noncurrent4.77
Operating Lease Right Of Use Asset76.22
Total Assets614.16
Liabilities
Accounts Payable, Current AC5.35
Accrued Liabilities, Current AC17.05
Other Liabilities, Current10.52
Deferred Revenue, Current DE19.06
Total Current Liabilities51.98
Total Long-term Debt0.00
Deferred Revenue and Credits, Noncurrent LI29.52
Other liabilities, Noncurrent59.15
Operating Lease Liability Current10.52
Operating Lease Liability Noncurrent58.12
Success Payment Liability0.96
Total Liabilities140.65
Stockholders' Equity
Common Stock Value0.09
Additional Paid In Capital Common Stock1,247.08
Retained Earnings / Accumulated Deficit-774.05
Other Equity0.39
Common Stockholder's Equity473.51
Total Stockholder's Equity473.51
Liabilities & Stockholder's Equity614.16
4 historic quarters locked

Sign in to unlock the full Verve Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Verve Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-070911

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.